{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:15:42Z","timestamp":1794014142519,"version":"4.8.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1477-7525-7-102","type":"journal-article","created":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T14:15:55Z","timestamp":1261577755000},"source":"Crossref","is-referenced-by-count":473,"title":["Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008"],"prefix":"10.1186","volume":"7","author":[{"given":"Ali","family":"Montazeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,23]]},"reference":[{"key":"619_CR1","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.clinthera.2007.12.031","volume":"29","author":"SJ Coons","year":"2007","unstructured":"Coons SJ: Health-related quality of life: let's measure and report it appropriately. Clinical Therapeutics 2007, 29: 2746\u20132747. 10.1016\/j.clinthera.2007.12.031","journal-title":"Clinical Therapeutics"},{"key":"619_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1023\/A:1022232624891","volume":"12","author":"A Montazeri","year":"2003","unstructured":"Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR: How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer. Qual Life Res 2003, 12: 157\u2013166. 10.1023\/A:1022232624891","journal-title":"Qual Life Res"},{"key":"619_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1756-9966-27-32","volume":"27","author":"A Montazeri","year":"2008","unstructured":"Montazeri A: Health-related quality of life in breast cancer patients: a bibliographic of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008, 27: 32. 10.1186\/1756-9966-27-32","journal-title":"J Exp Clin Cancer Res"},{"key":"619_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/PPO.0b013e3181b9c5b9","volume":"15","author":"PC Trask","year":"2009","unstructured":"Trask PC, Hsu MA, McQuellon R: Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer J 2009, 15: 435\u2013440. 10.1097\/PPO.0b013e3181b9c5b9","journal-title":"Cancer J"},{"key":"619_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","volume":"10","author":"C Quinten","year":"2009","unstructured":"Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A, EORTC Clinical Groups: Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009, 10: 865\u2013871. 10.1016\/S1470-2045(09)70200-1","journal-title":"Lancet Oncol"},{"key":"619_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/S1478951509990216","volume":"7","author":"GE Grande","year":"2009","unstructured":"Grande GE, Farquhar MC, Barclay SI, Todd CJ: Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients. Palliat Support Care 2009, 7: 289\u2013297. 10.1017\/S1478951509990216","journal-title":"Palliat Support Care"},{"key":"619_CR7","doi-asserted-by":"crossref","unstructured":"van Heijl M, Sprangers MA, de Boer AG, Lagarde SM, Reitsma HB, Busch OR, Tilanus HW, van Lanschot JJ, van Berge Henegouwen MI: Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer. Ann Surg Oncol, in press.","DOI":"10.1245\/s10434-009-0731-y"},{"key":"619_CR8","unstructured":"US Food and Drug Administration: Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. [ http:\/\/www.fda.gov\/ohrms\/dockets\/dockets\/06d0044\/06d0044.htm ]"},{"key":"619_CR9","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2008.03.017","volume":"44","author":"F Efficace","year":"2008","unstructured":"Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B: Health-related quality of life assessment and reported outcomes in leukaemia randomized controlled trials: a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008, 44: 1497\u20131506. 10.1016\/j.ejca.2008.03.017","journal-title":"Eur J Cancer"},{"key":"619_CR10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1600-0609.2009.01254.x","volume":"82","author":"F Efficace","year":"2009","unstructured":"Efficace F, Vignetti M, Mandelli F: Asking patients with hematological malignancies: 'how do you fee?' Does it really provide independent prognostic information for survival? Eur J Haematol 2009, 82: 484\u2013485. 10.1111\/j.1600-0609.2009.01254.x","journal-title":"Eur J Haematol"},{"key":"619_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/1097-0142(19820715)50:2<326::AID-CNCR2820500227>3.0.CO;2-G","volume":"50","author":"JL Pater","year":"1982","unstructured":"Pater JL, Loeb M: Non-anatomic prognostic factors in carcinoma of the lung: a multivariate analysis. Cancer 1982, 50: 326\u2013331. 10.1002\/1097-0142(19820715)50:2<326::AID-CNCR2820500227>3.0.CO;2-G","journal-title":"Cancer"},{"key":"619_CR12","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJM198506133122406","volume":"312","author":"BR Cassileth","year":"1985","unstructured":"Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C: Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 1985, 312: 1551\u2013555. 10.1056\/NEJM198506133122406","journal-title":"N Engl J Med"},{"key":"619_CR13","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1056\/NEJM198712103172402","volume":"317","author":"A Coates","year":"1987","unstructured":"Coates A, Gebski V, Bishop JF, Jeal PN, Woods RL, Snyder R, Tattersall MH, Byrne M, Harvey V, Gill G: Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategy. N Engl J Med 1987, 317: 1490\u20131495. 10.1056\/NEJM198712103172402","journal-title":"N Engl J Med"},{"key":"619_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0167-8140(89)90091-1","volume":"15","author":"S Kaasa","year":"1989","unstructured":"Kaasa S, Mastekaasa A, Lund E: Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. Radiother Oncol 1989, 15: 235\u2013242. 10.1016\/0167-8140(89)90091-1","journal-title":"Radiother Oncol"},{"key":"619_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0885-3924(95)00056-5","volume":"10","author":"L Degner","year":"1995","unstructured":"Degner L, Sloan J: Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 1995, 10: 423\u2013431. 10.1016\/0885-3924(95)00056-5","journal-title":"J Pain Symptom Manage"},{"key":"619_CR16","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/bjc.1996.300","volume":"73","author":"GI Ringdal","year":"1996","unstructured":"Ringdal GI, G\u00f6testam KG, Kaasa S, Kvinnsland S, Ringdal K: Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer 1996, 73: 1594\u20131599.","journal-title":"Br J Cancer"},{"key":"619_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0885-3924(95)00135-2","volume":"11","author":"M Tamburini","year":"1996","unstructured":"Tamburini M, Brunelli C, Rosso S, Ventafridda V: Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage 1996, 11: 32\u2013341. 10.1016\/0885-3924(95)00135-2","journal-title":"J Pain Symptom Manage"},{"key":"619_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0959-8049(97)00049-X","volume":"33","author":"A Coates","year":"1997","unstructured":"Coates A, Porzsolt F, Osoba D: Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997, 33: 1025\u20131030. 10.1016\/S0959-8049(97)00049-X","journal-title":"Eur J Cancer"},{"key":"619_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1026442201191","volume":"6","author":"J Dancey","year":"1997","unstructured":"Dancey J, Zee B, Osoba D, Whitehead M, Lu F, Kaizer L, Latreille J, Pater JL: Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 1997, 6: 151\u2013158. 10.1023\/A:1026442201191","journal-title":"Qual Life Res"},{"key":"619_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-T","volume":"83","author":"VT Chang","year":"1998","unstructured":"Chang VT, Thaler HT, Polyak TA, Kornblith AB, Lepore JM, Portenoy RK: Quality of life and survival: the role of multidimensional symptom assessment. Cancer 1998, 83: 173\u2013179. 10.1002\/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-T","journal-title":"Cancer"},{"key":"619_CR21","first-page":"453","volume":"13","author":"PT Lam","year":"2007","unstructured":"Lam PT, Leung MW, Tse CY: Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J 2007, 13: 453\u2013459.","journal-title":"Hong Kong Med J"},{"key":"619_CR22","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1002\/1097-0142(19910615)67:12<3131::AID-CNCR2820671232>3.0.CO;2-4","volume":"67","author":"PA Ganz","year":"1991","unstructured":"Ganz PA, Lee JJ, Siau J: Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 1991, 67: 3131\u20133135. 10.1002\/1097-0142(19910615)67:12<3131::AID-CNCR2820671232>3.0.CO;2-4","journal-title":"Cancer"},{"key":"619_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1378\/chest.106.6.324S","volume":"106","author":"JC Ruckdeschel","year":"1994","unstructured":"Ruckdeschel JC, Piantadosi S: Quality of life in lung cancer surgical adjuvant trial. Chest 1994, 106: 324\u2013328. 10.1378\/chest.106.6.324S","journal-title":"Chest"},{"key":"619_CR24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1200\/JCO.1994.12.3.601","volume":"12","author":"CL Loprinzi","year":"1994","unstructured":"Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, Bartel J, Law M, Bateman M, Klatt NE, et al.: Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol 1994, 12: 601\u2013607.","journal-title":"J Clin Oncol"},{"key":"619_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0169-5002(94)00392-Z","volume":"12","author":"GF Buccheri","year":"1995","unstructured":"Buccheri GF, Ferrigno D, Tamburini M, Brunelli C: The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer 1995, 12: 45\u201358. 10.1016\/0169-5002(94)00392-Z","journal-title":"Lung Cancer"},{"key":"619_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1183\/09031936.98.11010173","volume":"11","author":"G Buccheri","year":"1998","unstructured":"Buccheri G: Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 1998, 11: 173\u2013178. 10.1183\/09031936.98.11010173","journal-title":"Eur Respir J"},{"key":"619_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<333::AID-CNCR10>3.0.CO;2-Q","volume":"85","author":"JE Herndon","year":"1999","unstructured":"Herndon JE, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J: Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999, 85: 333\u2013340. 10.1002\/(SICI)1097-0142(19990115)85:2<333::AID-CNCR10>3.0.CO;2-Q","journal-title":"Cancer"},{"key":"619_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0167-8140(00)00158-4","volume":"55","author":"H Langendijk","year":"2000","unstructured":"Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M: The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000, 55: 19\u201325. 10.1016\/S0167-8140(00)00158-4","journal-title":"Radiother Oncol"},{"key":"619_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1378\/chest.117.1.73","volume":"117","author":"CM Burrows","year":"2000","unstructured":"Burrows CM, Mathews WC, Colt HG: Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000, 117: 73\u201378. 10.1378\/chest.117.1.73","journal-title":"Chest"},{"key":"619_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0169-5002(00)00179-3","volume":"31","author":"A Montazeri","year":"2001","unstructured":"Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR: Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001, 31: 233\u2013240. 10.1016\/S0169-5002(00)00179-3","journal-title":"Lung Cancer"},{"key":"619_CR31","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0360-3016(01)01604-2","volume":"50","author":"RM Auchter","year":"2001","unstructured":"Auchter RM, Scholtens D, Adak S, Wanger H, Cella DF, Mehta MP: Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Int J Radiat Oncol Biol Phys 2001, 50: 1199\u20131206. 10.1016\/S0360-3016(01)01604-2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"619_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1015048908822","volume":"11","author":"CM Moinpour","year":"2002","unstructured":"Moinpour CM, Lyons B, Grevstad PK, Lovato LC, Growley J, Czaplicki K, Buckner ZM, Ganz PA, Kelly K, Gandara DR: Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial. Qual Life Res 2002, 11: 115\u2013126. 10.1023\/A:1015048908822","journal-title":"Qual Life Res"},{"key":"619_CR33","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1002\/cncr.10608","volume":"94","author":"Y Nakahara","year":"2002","unstructured":"Nakahara Y, Mochizuki Y, Miyamoto Y, Tanaka A, Kawamura T, Sasaki S, Nakahara Y, Katsura Y: Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma. Cancer 2002, 94: 3006\u20133015. 10.1002\/cncr.10608","journal-title":"Cancer"},{"key":"619_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1023\/A:1015257121369","volume":"11","author":"MJ Naughton","year":"2002","unstructured":"Naughton MJ, Herndon JE, Shumaker SA, Miller AA, Kornblith AB, Chao D, Hollan J: The health - related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033. Qual Life Res 2002, 11: 235\u2013248. 10.1023\/A:1015257121369","journal-title":"Qual Life Res"},{"key":"619_CR35","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1200\/JCO.2003.07.128","volume":"21","author":"DT Eton","year":"2003","unstructured":"Eton DT, Fairclough DJ, Cella D, Yount SE, Bonomi P, Johnson DH: Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from eastern cooperative oncology group study 5592. J Clin Oncol 2003, 21: 1536\u20131543. 10.1200\/JCO.2003.07.128","journal-title":"J Clin Oncol"},{"key":"619_CR36","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1023\/B:QURE.0000037481.36604.eb","volume":"13","author":"M Dharma-Wardene","year":"2004","unstructured":"Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D: Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 2004, 13: 1209\u20131216. 10.1023\/B:QURE.0000037481.36604.eb","journal-title":"Qual Life Res"},{"key":"619_CR37","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2004.09.147","volume":"22","author":"AK Nowak","year":"2004","unstructured":"Nowak AK, Stockler MR, Byrne MJ: Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol 2004, 22: 3172\u20133180. 10.1200\/JCO.2004.09.147","journal-title":"J Clin Oncol"},{"key":"619_CR38","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.1200\/JCO.2005.02.527","volume":"23","author":"P Maione","year":"2005","unstructured":"Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, Cigolari S, Rosetti F, Piazza E, Robbiati SF, Bertetto O, Novello S, Migliorino MR, Favaretto A, Spatafora M, Ferra\u00f9 F, Frontini L, Bearz A, Repetto L, Gridelli C, Barletta E, Barzelloni ML, Iaffaioli RV, De Maio E, Di Maio M, De Feo G, Sigoriello G, Chiodini P, Cioffi A, Guardasole V, Angelini V, Rossi A, Bilancia D, Germano D, Lamberti A, Pontillo V, Brancaccio L, Renda F, Romano F, Esani G, Gambaro A, Vinante O, Azzarello G, Clerici M, Bollina R, Belloni P, Sannicol\u00f2 M, Ciuffreda L, Parello G, Cabiddu M, Sacco C, Sibau A, Porcile G, Castiglione F, Ostellino O, Monfardini S, Stefani M, Scagliotti G, Selvaggi G, De Marinis F, Martelli O, Gasparini G, Morabito A, Gattuso D, Colucci G, Galetta D, Giotta F, Gebbia V, Borsellino N, Testa A, Malaponte E, Capuano MA, Angiolillo M, Sollitto F, Tirelli U, Spazzapan S, Adamo V, Altavilla G, Scimone A, Hopps MR, Tartamella F, Ianniello GP, Tinessa V, Failla G, Bordonaro R, Gebbia N, Valerio MR, D'Aprile M, Veltri E, Tonato M, Darwish S, Romito S, Carrozza F, Barni S, Ardizzoia A, Corradini GM, Pavia G, Belli M, Colantuoni G, Galligioni E, Caffo O, Labianca R, Quadri A, Cortesi E, D'Auria G, Fava S, Calcagno A, Luporini G, Locatelli MC, Di Costanzo F, Gasperoni S, Isa L, Candido P, Gaion F, Palazzolo G, Nettis G, Annamaria A, Rinaldi M, Lopez M, Felletti R, Di Negro GB, Rossi N, Calandriello A, Maiorino L, Mattioli R, Celano A, Schiavon S, Illiano A, Raucci CA, Caruso M, Foa P, Tonini G, Curcio C, Cazzaniga M: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005, 23: 6865\u20136872. 10.1200\/JCO.2005.02.527","journal-title":"J Clin Oncol"},{"key":"619_CR39","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1200\/JCO.2005.09.158","volume":"23","author":"J Brown","year":"2005","unstructured":"Brown J, Thorpe H, Napp V, Fairlamb DJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG, Stephens RJ, Waller D, West P, Peake MD: Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol 2005, 23: 7417\u2013727. 10.1200\/JCO.2005.09.158","journal-title":"J Clin Oncol"},{"key":"619_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2407-5-72","volume":"5","author":"SJ Martins","year":"2005","unstructured":"Martins SJ, Ho N, Cavamura SO, Harada CM, Yamamoto CA, Takagaki TY: Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer. BMC Cancer 2005, 5: 72. 10.1186\/1471-2407-5-72","journal-title":"BMC Cancer"},{"key":"619_CR41","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/annonc\/mdl183","volume":"17","author":"F Efficace","year":"2006","unstructured":"Efficace F, Bottomley A, Smit EF, Lianes P, Legrand C, Debruyne C, Schramel F, Smit HJ, Gaafar R, Biesma B, Manegold C, Coens C, Giaccone G, Van Meerbeeck J, the EORTC Lung Cancer Group and Quality of Life Unit: Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 2006, 17: 1698\u20131704. 10.1093\/annonc\/mdl183","journal-title":"Ann Oncol"},{"key":"619_CR42","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1556-0864(15)30411-1","volume":"1","author":"S Sundstr\u00f8m","year":"2006","unstructured":"Sundstr\u00f8m S, Bremnes RM, Brunsvig P, Aaseb\u00f8 U, Kaasa S, Norwegian Lung Cancer Study Group: Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy? J Thorac Oncol 2006, 1: 816\u2013824. 10.1097\/01243894-200610000-00010","journal-title":"J Thorac Oncol"},{"key":"619_CR43","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1200\/JCO.2007.12.5294","volume":"25","author":"A Bottomley","year":"2007","unstructured":"Bottomley A, Coens C, Efficace F, Gaafar R, Manegold C, Burgers S, Vincent M, Legrand C, van Meerbeeck JP, EORTC-NCIC: Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma. J Clin Oncol 2007, 25: 5770\u20135776. 10.1200\/JCO.2007.12.5294","journal-title":"J Clin Oncol"},{"key":"619_CR44","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.ejca.2007.05.002","volume":"43","author":"R Fielding","year":"2007","unstructured":"Fielding R, Wong WS: Quality of life as a predictor of cancer survival among Chinese liver and lung cancer patients. Eur J Cancer 2007, 43: 1723\u20131730. 10.1016\/j.ejca.2007.05.002","journal-title":"Eur J Cancer"},{"key":"619_CR45","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/annonc\/mdn064","volume":"19","author":"W Jacot","year":"2008","unstructured":"Jacot W, Colinet B, Bertrand D, Lacombe S, Bozonnat MC, Daur\u00e8s JP, Pujol JL, OncoLR health network: Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 2008, 19: 1458\u20131464. 10.1093\/annonc\/mdn064","journal-title":"Ann Oncol"},{"key":"619_CR46","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1200\/JCO.1992.10.12.1833","volume":"10","author":"A Coates","year":"1992","unstructured":"Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byne M, Forbes JF: Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. J Clin Oncol 1992, 10: 1833\u20131838.","journal-title":"J Clin Oncol"},{"key":"619_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/bjc.1993.62","volume":"67","author":"SC Fraser","year":"1993","unstructured":"Fraser SC, Ramirez AJ, Ebbes SR, Fallowfield LJ, Dobbs HJ, Richards MA, Bates T, Baum M: A daily diary for quality of life measurement in advanced breast cancer trials. Br J Cancer 1993, 67: 341\u2013346.","journal-title":"Br J Cancer"},{"key":"619_CR48","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/jnci\/87.17.1316","volume":"187","author":"AD Seidman","year":"1995","unstructured":"Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M, et al.: Quality of life in phase II trials-A study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel, plus granulocyte colony stimulating factor. J Natl Cancer Inst 1995, 187: 1316\u20131322. 10.1093\/jnci\/87.17.1316","journal-title":"J Natl Cancer Inst"},{"key":"619_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jnci\/88.10.661","volume":"88","author":"S Tross","year":"1996","unstructured":"Tross S, Herndon J, Korzun A, Kornblith AB, Cella DF, Herndon JF, Raich P, Johnson A, Kiang DT, Perloff M, Norton L, Wood W, Holland JC, From the Cancer and Leukemia Group B: Psychosocial symptoms and disease-free and overall survival in women with stage II breast cancer. J Natl Cancer Inst 1996, 88: 661\u2013667. 10.1093\/jnci\/88.10.661","journal-title":"J Natl Cancer Inst"},{"key":"619_CR50","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(98)11392-2","volume":"16","author":"M Watson","year":"1999","unstructured":"Watson M, Haviland JS, Greer S, Davidson J, Bliss JM: Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999, 16: 1331\u20131336. 10.1016\/S0140-6736(98)11392-2","journal-title":"Lancet"},{"key":"619_CR51","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.2000.18.22.3768","volume":"18","author":"AS Coates","year":"2000","unstructured":"Coates AS, Hurny C, Peterson HF, Bernhard J, Castinglione-Gertsch M, Gelberg D, Goldhirsch A: Quality of life scores predict outcome in metastatic but not early breast cancer. J Clin Oncol 2000, 18: 3768\u20133774.","journal-title":"J Clin Oncol"},{"key":"619_CR52","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0959-8049(00)00144-1","volume":"36","author":"JA Kramer","year":"2000","unstructured":"Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG, van Hoorebeeck I, Paridaens R: Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in firs-line chemotherapy in advanced breast cancer. Eur J Cancer 2000, 36: 1498\u20131506. 10.1016\/S0959-8049(00)00144-1","journal-title":"Eur J Cancer"},{"key":"619_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s005950050055","volume":"30","author":"K Shimozuma","year":"2000","unstructured":"Shimozuma K, Sonoo H, Ichihara K, Tanaka K: The prognostic value of quality of life scores: preliminary results of an analysis of patients with breast cancer. Surg Today 2000, 30: 255\u2013261. 10.1007\/s005950050055","journal-title":"Surg Today"},{"key":"619_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1023\/A:1008396330433","volume":"11","author":"PN Butow","year":"2000","unstructured":"Butow PN, Coates AS, Dunn SM: Psychosocial predictors of survival: metastatic breast cancer. Ann Oncol 2000, 11: 469\u2013474. 10.1023\/A:1008396330433","journal-title":"Ann Oncol"},{"key":"619_CR55","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/S0959-8049(02)00775-X","volume":"39","author":"ML Luoma","year":"2003","unstructured":"Luoma ML, Hakamies-Blomqvist L, Sjostrom J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmstrom P, Valvere V, Tennvall L, Blomqvist C: Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 2003, 39: 1370\u20131376. 10.1016\/S0959-8049(02)00775-X","journal-title":"Eur J Cancer"},{"key":"619_CR56","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1200\/JCO.2004.08.048","volume":"22","author":"EP Winer","year":"2004","unstructured":"Winer EP, Berry DA, Woolf S, Duggan D, Kornblith A, Harris LN, Michaelson RA, Kirshner JA, Fleming GF, Perry MC, Graham ML, Sharp SA, Keresztes R, Henderson IC, Hudis C, Muss H, Norton L: Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol 2004, 22: 2061\u20132068. 10.1200\/JCO.2004.08.048","journal-title":"J Clin Oncol"},{"key":"619_CR57","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2004.02.060","volume":"22","author":"F Efficace","year":"2004","unstructured":"Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Sprangers MA, Bottomley A: Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 2004, 22: 3381\u20133388. 10.1200\/JCO.2004.02.060","journal-title":"J Clin Oncol"},{"key":"619_CR58","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.ejca.2004.01.014","volume":"40","author":"F Efficace","year":"2004","unstructured":"Efficace F, Biganzoli L, Piccart M, Coens C, van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A: Baseline health-related quality of life data as prognostic factors in a phase III multicenter study of women with metastatic breast cancer. Eur J Cancer 2004, 40: 1021\u20131030. 10.1016\/j.ejca.2004.01.014","journal-title":"Eur J Cancer"},{"key":"619_CR59","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1200\/JCO.2004.12.091","volume":"22","author":"PJ Goodwin","year":"2004","unstructured":"Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KT, Trudeau Me, Koo J, Hood N: Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 2004, 22: 4184\u20134192. 10.1200\/JCO.2004.12.091","journal-title":"J Clin Oncol"},{"key":"619_CR60","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.ejca.2005.01.012","volume":"41","author":"M Watson","year":"2005","unstructured":"Watson M, Homewood J, Haviland J, Bliss J: Influence of psychosocial response on breast cancer survival: 10-year follow-up of a population-based cohort. European Journal of Cancer 2005, 41: 1710\u20131714. 10.1016\/j.ejca.2005.01.012","journal-title":"European Journal of Cancer"},{"key":"619_CR61","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/sj.bjc.6603091","volume":"94","author":"US Lehto","year":"2006","unstructured":"Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu Lehtinen P: Baseline psychosocial predictors of survival in localized breast cancer. Br J Cancer 2006, 94: 1245\u20131252. 10.1038\/sj.bjc.6603091","journal-title":"Br J Cancer"},{"key":"619_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00520-006-0165-z","volume":"15","author":"D Gupta","year":"2007","unstructured":"Gupta D, Granick J, Grutsch JF, Lis CG: The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer 2007, 15: 387\u2013393. 10.1007\/s00520-006-0165-z","journal-title":"Support Care Cancer"},{"key":"619_CR63","first-page":"209","volume":"105","author":"M Groenvold","year":"2007","unstructured":"Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT: Psychosocial distress and fatigue predicted recurrence and survival in primary breast cancer patients. Br J Cancer 2007, 105: 209\u2013219.","journal-title":"Br J Cancer"},{"key":"619_CR64","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1365-2168.2000.01383-8.x","volume":"87","author":"JM Blazeby","year":"2000","unstructured":"Blazeby JM, Brookes ST, Alderson D: Prognostic value of quality of life scores in patients with oesophageal cancer. Br J Surg 2000, 87: 362\u2013373. 10.1046\/j.1365-2168.2000.01383-8.x","journal-title":"Br J Surg"},{"key":"619_CR65","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/gut.49.2.227","volume":"49","author":"JM Blazeby","year":"2001","unstructured":"Blazeby JM, Brookes ST, Alderson D: The prpognostic value of quality of life scores during treatment for oesophageal cancer. Gut 2001, 49: 227\u2013230. 10.1136\/gut.49.2.227","journal-title":"Gut"},{"key":"619_CR66","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.ijrobp.2003.09.100","volume":"58","author":"FM Fang","year":"2004","unstructured":"Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY: Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2004, 58: 1394\u20131404. 10.1016\/j.ijrobp.2003.09.100","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"619_CR67","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1200\/JCO.2004.08.154","volume":"22","author":"I Chau","year":"2004","unstructured":"Chau I, Norman AR, Cunningham D, Waters JS, Oates J: Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer: pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 2004, 22: 2395\u20132403. 10.1200\/JCO.2004.08.154","journal-title":"J Clin Oncol"},{"key":"619_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11136-008-9307-8","volume":"17","author":"SH Park","year":"2008","unstructured":"Park SH, Cho MS, Kim YS, Hong J, Nam E, Park J, Cho EK, Shin DB, Lee JH, Lee WK: Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Qual Life Res 2008, 17: 207\u2013214. 10.1007\/s11136-008-9307-8","journal-title":"Qual Life Res"},{"key":"619_CR69","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2036.2007.03589.x","volume":"27","author":"H Bergquist","year":"2008","unstructured":"Bergquist H, Johnsson A, Hammerlid E, Wenger U, Lundell L, Ruth M: Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation. Aliment Pharmacol Ther 2008, 27: 385\u2013395. 10.1111\/j.1365-2036.2007.03589.x","journal-title":"Aliment Pharmacol Ther"},{"key":"619_CR70","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/sj.bjc.6604248","volume":"98","author":"M McKernan","year":"2008","unstructured":"McKernan M, Mcmillan Dc, Anderson JR, Angerson WJ, Stuart RC: The relationship between quality of life (EORT QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 2008, 98: 888\u2013893. 10.1038\/sj.bjc.6604248","journal-title":"Br J Cancer"},{"key":"619_CR71","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1442-2050.2008.00814.x","volume":"21","author":"LA Healy","year":"2008","unstructured":"Healy LA, Ryan AM, Moore J, Rowley S, Ravi N, Byrne PJ, Reynolds JV: Health-related quality of life assessment at presentation may predict complications and early relapse in patients with localized cancer of the esophagus. Dis Esophagus 2008, 21: 522\u2013528. 10.1111\/j.1442-2050.2008.00814.x","journal-title":"Dis Esophagus"},{"key":"619_CR72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1200\/JCO.1996.14.1.171","volume":"14","author":"S Earlam","year":"1996","unstructured":"Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG: Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996, 14: 171\u2013175.","journal-title":"J Clin Oncol"},{"key":"619_CR73","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0959-8049(02)00098-9","volume":"38","author":"NR Maisey","year":"2002","unstructured":"Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D: Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002, 38: 1351\u20131357. 10.1016\/S0959-8049(02)00098-9","journal-title":"Eur J Cancer"},{"key":"619_CR74","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00520-006-0100-3","volume":"14","author":"CG Lis","year":"2006","unstructured":"Lis CG, Gupta D, Granick J, Grutsch JF: Can patient satisfaction with quality of life predict survival in advanced colorectal cancer? Support Care Cancer 2006, 14: 1104\u20131110. 10.1007\/s00520-006-0100-3","journal-title":"Support Care Cancer"},{"key":"619_CR75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejca.2005.07.025","volume":"42","author":"F Efficace","year":"2006","unstructured":"Efficace F, Bottomley A, Coens C, Van Steen K, Conroy T, Sch\u00f6ffski P, Schmoll H, Van Cutsem E, K\u00f6hne CH: Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 2006, 42: 42\u201349. 10.1016\/j.ejca.2005.07.025","journal-title":"Eur J Cancer"},{"key":"619_CR76","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1200\/JCO.2007.12.3117","volume":"26","author":"F Efficace","year":"2008","unstructured":"Efficace F, Innominato PF, Bjarnason G, Coens C, Humblet Y, Tumolo S, Genet D, Tampellini M, Bottomley A, Garufi C, Focan C, Giacchetti S, L\u00e9vi F, Chronotherapy Group of the European Organisation for Research and Treatment of Cancer: Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol 2008, 26: 2020\u20132026. 10.1200\/JCO.2007.12.3117","journal-title":"J Clin Oncol"},{"key":"619_CR77","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2567::AID-CNCR24>3.0.CO;2-X","volume":"83","author":"MF De Boer","year":"1998","unstructured":"De Boer MF, Borne B, Pruyn JF, Ryckman RM, Volovics L, Knegt PP, Meeuwis CA, Mesters I, Verwoerd CD: Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study. Cancer 1998, 83: 2567\u20132579. 10.1002\/(SICI)1097-0142(19981215)83:12<2567::AID-CNCR24>3.0.CO;2-X","journal-title":"Cancer"},{"key":"619_CR78","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0959-8049(00)00385-3","volume":"37","author":"A de Graeff","year":"2001","unstructured":"de Graeff A, de Leeuw JR, Row WJ, Hordijk GJ, Blijham GH, Winnubst JA: Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 2001, 37: 332\u2013339. 10.1016\/S0959-8049(00)00385-3","journal-title":"Eur J Cancer"},{"key":"619_CR79","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/cncr.20010","volume":"100","author":"FM Fang","year":"2004","unstructured":"Fang FM, Liu YT, Tang Y, Wang CJ, Ko SF: Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 2004, 100: 425\u2013432. 10.1002\/cncr.20010","journal-title":"Cancer"},{"key":"619_CR80","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/archotol.132.1.27","volume":"132","author":"HM Mehanna","year":"2006","unstructured":"Mehanna HM, Morton RP: Does quality of life predict long-term survival in head and neck cancer patients. Arch Otolaryngol Head Neck Surg 2006, 132: 27\u201331. 10.1001\/archotol.132.1.27","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"619_CR81","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/hed.20334","volume":"28","author":"M Nordgren","year":"2006","unstructured":"Nordgren M, Jannert M, Boysen M, et al.: Health-related quality of life in patients with pharyngeal carcinoma: a five year follow-up. Head Neck 2006, 28: 339\u2013349. 10.1002\/hed.20334","journal-title":"Head Neck"},{"key":"619_CR82","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/cncr.23080","volume":"110","author":"JC Coyne","year":"2007","unstructured":"Coyne JC, Pajak TF, Harris J, Konski A, Movsas B, Ang K, Watkins Bruner D, Radiation Therapy Oncology Group: Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study. Cancer 2007, 110: 2568\u20132575. 10.1002\/cncr.23080","journal-title":"Cancer"},{"key":"619_CR83","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2007.06.024","volume":"70","author":"F Siddiqui","year":"2008","unstructured":"Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, Jones C, Movsas B: Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys 2008, 70: 353\u2013360. 10.1016\/j.ijrobp.2007.06.024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"619_CR84","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1200\/JCO.2007.12.9510","volume":"26","author":"CA Karvonen-Gutierrez","year":"2008","unstructured":"Karvonen-Gutierrez CA, Ronis DI, Fowler KE, Terrell JE, gruber SB, Duffy SA: Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 2008, 26: 2754\u20132760. 10.1200\/JCO.2007.12.9510","journal-title":"J Clin Oncol"},{"key":"619_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1749-4486.2008.01666.x","volume":"33","author":"HM Mehanna","year":"2008","unstructured":"Mehanna HM, De Boer MF, Morton RP: The association of psycho-social and survival in head and neck cancer. Clin Otolaryngol 2008, 33: 83\u201389. 10.1111\/j.1749-4486.2008.01666.x","journal-title":"Clin Otolaryngol"},{"key":"619_CR86","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.1988.6.11.1753","volume":"6","author":"BR Cassileth","year":"1988","unstructured":"Cassileth BR, Walsh WP, Lusk EJ: Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis. J Clin Oncol 1988, 6: 1753\u20131759.","journal-title":"J Clin Oncol"},{"key":"619_CR87","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/0959-8049(93)90115-V","volume":"29","author":"A Coates","year":"1993","unstructured":"Coates A, Thomson D, McLeod GR, Hersey P, Gill PG, Olver IN, Kefford R, Lowenthal RM, Beadle G, Walpole E: Prognostic value of quality of life scores in a trial of Chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993, 29: 1731\u20131734. 10.1016\/0959-8049(93)90115-V","journal-title":"Eur J Cancer"},{"key":"619_CR88","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1200\/JCO.1999.17.7.2256","volume":"17","author":"PN Butow","year":"1999","unstructured":"Butow PN, Coates AS, Dunn SM: Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 1999, 17: 2256.","journal-title":"J Clin Oncol"},{"key":"619_CR89","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1054\/bjoc.2000.1471","volume":"83","author":"JE Brown","year":"2000","unstructured":"Brown JE, Butow PN, Culjak G, Coates AS, Dunn SM: Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer 2000, 83: 1448\u20131453. 10.1054\/bjoc.2000.1471","journal-title":"Br J Cancer"},{"key":"619_CR90","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0959-8049(03)00372-1","volume":"39","author":"V Chiarion-Sileni","year":"2003","unstructured":"Chiarion-Sileni V, Del Bianco P, De Salvo GL, Lo Re G, Romanini A, Labianca R, Nortilli R, Corgna E, Dalla Palma M, Lo Presti G, Ridolfi R, Italian Melanoma Intergroup (IMI): Quality of life evaluation in a randomized trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer 2003, 39: 1577\u20131585. 10.1016\/S0959-8049(03)00372-1","journal-title":"Eur J Cancer"},{"key":"619_CR91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jpsychores.2007.01.001","volume":"63","author":"US Lehto","year":"2007","unstructured":"Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu Lehtinen P: Baseline psychosocial predictors of survival in localized melanoma. J Psychosom Res 2007, 63: 9\u201315. 10.1016\/j.jpsychores.2007.01.001","journal-title":"J Psychosom Res"},{"key":"619_CR92","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/00006842-199409000-00008","volume":"56","author":"MA Andrykowski","year":"1994","unstructured":"Andrykowski MA, brady MJ, Henslee-Downey PJ: Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med 1994, 56: 432\u2013439.","journal-title":"Psychosom Med"},{"key":"619_CR93","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.1996.14.6.1753","volume":"14","author":"IF Tannock","year":"1996","unstructured":"Tannock IF, Osoba D, Stockler MR, Ernst DS, Neville AJ, Moore MJ, Armitage GR, Wilson JJ, Venner PM, Coppin CM, Murphy KC: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 1996, 14: 1753\u20131755.","journal-title":"J Clin Oncol"},{"key":"619_CR94","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1365-2141.1997.222667.x","volume":"97","author":"F Wisl\u00f8ff","year":"1997","unstructured":"Wisl\u00f8ff F, Hjorth M: Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol 1997, 97: 29\u201337. 10.1046\/j.1365-2141.1997.222667.x","journal-title":"Br J Haematol"},{"key":"619_CR95","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1200\/JCO.2000.18.3.646","volume":"18","author":"CA Meyers","year":"2000","unstructured":"Meyers CA, Hess KR, Yung WK, Levin VA: Cognitive function as predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 2000, 18: 646\u2013650.","journal-title":"J Clin Oncol"},{"key":"619_CR96","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1385\/MO:18:1:85","volume":"18","author":"M Jerkeman","year":"2001","unstructured":"Jerkeman M, Kaasa S, Hjermstad M, Kval\u00f8y S, Cavallin-Stahl E: Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial. Med Oncol 2001, 18: 85\u201394. 10.1385\/MO:18:1:85","journal-title":"Med Oncol"},{"key":"619_CR97","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1200\/JCO.2003.04.166","volume":"21","author":"DF Roychowdhury","year":"2003","unstructured":"Roychowdhury DF, Hayden A, Liepa AM: Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 2003, 21: 673\u2013678. 10.1200\/JCO.2003.04.166","journal-title":"J Clin Oncol"},{"key":"619_CR98","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000069862","volume":"26","author":"S Sehlen","year":"2003","unstructured":"Sehlen S, Lenk M, Hollenhorst H, Schymura B, Aydemir U, Herschbach P, Duhmke E: Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy. Onkologie 2003, 26: 38\u201343. 10.1159\/000069862","journal-title":"Onkologie"},{"key":"619_CR99","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1200\/JCO.2004.07.089","volume":"22","author":"L Collette","year":"2004","unstructured":"Collette L, Andel GA, Bottomley A, Oosterhof G, Albrecht W, Rrijke TM: Is baseline quality of life useful for predicting survival with hormone-Refractory prostate cancer? A pooled Analysis of three studies of the European organization for research and treatment of cancer genitourinary Group. J Clin Oncol 2004, 22: 3877\u20133885. 10.1200\/JCO.2004.07.089","journal-title":"J Clin Oncol"},{"key":"619_CR100","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1200\/JCO.2005.10.522","volume":"23","author":"BJ Monk","year":"2005","unstructured":"Monk BJ, Huang HQ, Cella D, Long HJ, Gynecologic oncology Group study: Quality of life outcome from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2005, 23: 4617\u20134625. 10.1200\/JCO.2005.10.522","journal-title":"J Clin Oncol"},{"key":"619_CR101","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1227\/01.NEU.0000170562.25335.C7","volume":"57","author":"PD Brown","year":"2005","unstructured":"Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, Clark MM, Buckner JC: A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005, 57: 495\u2013504. 10.1227\/01.NEU.0000170562.25335.C7","journal-title":"Neurosurgery"},{"key":"619_CR102","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11060-005-7020-9","volume":"76","author":"PD Brown","year":"2006","unstructured":"Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, Gupta L, Tang-Wai DF, Arusell RM, Clark MM, Buckner JC: Prospective study of quality of life adults with newly diagnosed high-grade gliomas. J Neurooncol 2006, 76: 283\u2013291. 10.1007\/s11060-005-7020-9","journal-title":"J Neurooncol"},{"key":"619_CR103","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/annonc\/mdl065","volume":"17","author":"W Yeo","year":"2006","unstructured":"Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B: Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 2006, 17: 1083\u20131089. 10.1093\/annonc\/mdl065","journal-title":"Ann Oncol"},{"key":"619_CR104","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1385\/IJGC:37:1:35","volume":"37","author":"CG Lis","year":"2006","unstructured":"Lis CG, Gupta D, Grutsch JF: Patient satisfaction with quality of life as a predictor of survival in pancreatic cancer. Int J Gastrointest Cancer 2006, 37: 35\u201344. 10.1385\/IJGC:37:1:35","journal-title":"Int J Gastrointest Cancer"},{"key":"619_CR105","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1200\/JCO.2005.04.0824","volume":"24","author":"D Dubois","year":"2006","unstructured":"Dubois D, Dhawan R, velde H, Esseltine D, Gupta S, Viala M, Loge C: Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. J Clin Oncol 2006, 24: 976\u2013982. 10.1200\/JCO.2005.04.0824","journal-title":"J Clin Oncol"},{"key":"619_CR106","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s11136-006-0003-2","volume":"15","author":"PW Sullivan","year":"2006","unstructured":"Sullivan PW, Nelson JB, Mulani PM, Sleep D: Quality of life as potential predictor morbidity and mortality in patients with metastastic hormone-refractory prostate cancer. Qual Life Res 2006, 15: 1297\u20131306. 10.1007\/s11136-006-0003-2","journal-title":"Qual Life Res"},{"key":"619_CR107","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1200\/JCO.2007.11.1476","volume":"25","author":"ME Mauer","year":"2007","unstructured":"Mauer ME, Taphoorn MJ, Bottomley A, Coens C, Efficace F, Sanson M, Brandes AA, Rijt CC, Bernsen HJ, Fr\u00e9nay M, Tijssen CC, Lacombe D, Bent MJ, EORTC Brain Cancer Group: Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol 2007, 25: 5731\u20135737. 10.1200\/JCO.2007.11.1476","journal-title":"J Clin Oncol"},{"key":"619_CR108","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/sj.bjc.6603876","volume":"97","author":"M Mauer","year":"2007","unstructured":"Mauer M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong R, Witte O, Caimcross JG, Efficace F, Mirimarnoff RO, Forsyth P, Bent MJ, Weller M, Bottomley A: The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study. Br J Cancer 2007, 97: 302\u2013307. 10.1038\/sj.bjc.6603876","journal-title":"Br J Cancer"},{"key":"619_CR109","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jclinepi.2006.10.006","volume":"60","author":"M Viala","year":"2007","unstructured":"Viala M, Bhakar AL, de la Loge C, Velde H, Esseltine D, Chang M, Dhawan R, Dubois D: Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis. J Clin Epidemiol 2007, 60: 670\u2013679. 10.1016\/j.jclinepi.2006.10.006","journal-title":"J Clin Epidemiol"},{"key":"619_CR110","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11136-008-9365-y","volume":"17","author":"F Bonnetain","year":"2008","unstructured":"Bonnetain F, Paoletti X, Collette S, Doffoel M, Bouch\u00e9 O, Raoul JL, Rougier P, Masskouri F, Barbare JC, Bedenne L: Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Qual Life Res 2008, 17: 831\u2013843. 10.1007\/s11136-008-9365-y","journal-title":"Qual Life Res"},{"key":"619_CR111","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ygyno.2007.08.088","volume":"108","author":"MS Carey","year":"2008","unstructured":"Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC: The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecol Oncol 2008, 108: 100\u2013105. 10.1016\/j.ygyno.2007.08.088","journal-title":"Gynecol Oncol"},{"key":"619_CR112","first-page":"98","volume":"6","author":"D Gupta","year":"2008","unstructured":"Gupta D, Grutsch JF, Lis CG: Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting. J Soc Integr Oncol 2008, 6: 98\u2013104.","journal-title":"J Soc Integr Oncol"},{"key":"619_CR113","first-page":"283","volume":"6","author":"DW Robinson","year":"2008","unstructured":"Robinson DW, Eisenberg DF, Cella D, Zhao N, de Boer C, De Witte M: The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. J Support Oncol 2008, 6: 283\u2013290.","journal-title":"J Support Oncol"},{"key":"619_CR114","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1600-0609.2008.01126.x","volume":"81","author":"K Strasser-Weippl","year":"2008","unstructured":"Strasser-Weippl K, Ludwig H: Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma. Eur J Haematol 2008, 81: 374\u2013379.","journal-title":"Eur J Haematol"},{"key":"619_CR115","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","volume":"26","author":"CC Gotay","year":"2008","unstructured":"Gotay CC, Kawamoto CT, Bottomoley A, Efficace F: The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008, 26: 1355\u20131363. 10.1200\/JCO.2007.13.3439","journal-title":"J Clin Oncol"},{"key":"619_CR116","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1002\/sim.1358","volume":"21","author":"K Van Steen","year":"2002","unstructured":"Van Steen K, Curran D, Kramer J, Molenberghs G, Van Verckem A, Bottomley A, Sylvester R: Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection. Stat Med 2002, 21: 3865\u20133884. 10.1002\/sim.1358","journal-title":"Stat Med"},{"key":"619_CR117","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00432-008-0438-7","volume":"135","author":"E Herrmann","year":"2009","unstructured":"Herrmann E, Gerss J, Bierer S, Kopke T, Bolenz C, Hertle L, Wulfing C: Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib. J Cancer Res Clin Oncol 2009, 135: 61\u201367. 10.1007\/s00432-008-0438-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Suppl 1","key":"619_CR118","first-page":"S36","volume":"24","author":"D Spiegel","year":"1997","unstructured":"Spiegel D: Psychosocial aspects of breast cancer treatment. Semin Oncol 1997,24(Suppl 1):S36-S47.","journal-title":"Semin Oncol"},{"key":"619_CR119","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.hoc.2008.04.010","volume":"22","author":"JS Gordon","year":"2008","unstructured":"Gordon JS: Mind-body medicine and cancer. Hematol Oncol Clin North Am 2008, 22: 683\u2013708. 10.1016\/j.hoc.2008.04.010","journal-title":"Hematol Oncol Clin North Am"},{"key":"619_CR120","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1300\/J010v46n04_02","volume":"46","author":"J Littrell","year":"2008","unstructured":"Littrell J: The mind-body connection: not just a theory anymore. Soc Work Health Care 2008, 46: 17\u201337. 10.1300\/J010v46n04_02","journal-title":"Soc Work Health Care"},{"key":"619_CR121","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.socscimed.2009.05.013","volume":"69","author":"M Jylh\u00e4","year":"2009","unstructured":"Jylh\u00e4 M: What is self-rated health and why does it predict mortality? Towards a unified conceptual model. Soc Sci Med 2009, 69: 307\u2013316. 10.1016\/j.socscimed.2009.05.013","journal-title":"Soc Sci Med"},{"key":"619_CR122","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/bjs.6621","volume":"96","author":"AR Harris","year":"2009","unstructured":"Harris AR, Bowley DM, Stannard A, Kurrimboccus S, Geh JI, Karandikar S: Socioeconomic deprivation adversely affects survival of patients with rectal cancer. Br J Surg 2009, 96: 763\u2013768. 10.1002\/bjs.6621","journal-title":"Br J Surg"},{"key":"619_CR123","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1471-2458-9-178","volume":"9","author":"T Braaten","year":"2009","unstructured":"Braaten T, Weiderpass E, Lund E: Socioeconomic differences in cancer survival: the Norwegian Women and Cancer Study. BMC Public Health 2009, 9: 178. 10.1186\/1471-2458-9-178","journal-title":"BMC Public Health"},{"key":"619_CR124","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.socscimed.2008.09.070","volume":"68","author":"HL Kelsall","year":"2009","unstructured":"Kelsall HL, Baglietto L, Muller D, Haydon AM, English DR, Giles GG: The effect of socioeconomic status on survival from colorectal cancer in the Melbourne Collaborative Cohort Study. Soc Sci Med 2009, 68: 290\u2013297. 10.1016\/j.socscimed.2008.09.070","journal-title":"Soc Sci Med"},{"key":"619_CR125","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cncr.23567","volume":"113","author":"TE Byers","year":"2008","unstructured":"Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, Fulton JP, Schymura MJ, Shen T, Van Heest S, Yin X, Patterns of Care Study Group: The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008, 113: 582\u2013591. 10.1002\/cncr.23567","journal-title":"Cancer"},{"key":"619_CR126","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1002\/cncr.23397","volume":"12","author":"SH Ou","year":"2008","unstructured":"Ou SH, Zell JA, Ziogas A, Anton-Culver H: Low socioeconomic status is a poor prognostic factor for survival in stage I non-small cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer 2008, 12: 2011\u20132020. 10.1002\/cncr.23397","journal-title":"Cancer"},{"key":"619_CR127","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1471-2407-7-193","volume":"7","author":"SL Gomez","year":"2007","unstructured":"Gomez SL, O'Malley CD, Stroup A, Shema SJ, Satariano WA: Longitudinal, population-based study of racial\/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer 2007, 7: 193. 10.1186\/1471-2407-7-193","journal-title":"BMC Cancer"},{"key":"619_CR128","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.bjc.6603980","volume":"97","author":"LG Shack","year":"2007","unstructured":"Shack LG, Rachet B, Brewster DH, Coleman MP: Socioeconomic inequalities in cancer survival in Scotland 1986\u20132000. Br J Cancer 2007, 97: 999\u20131004.","journal-title":"Br J Cancer"},{"key":"619_CR129","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/ijc.22979","volume":"121","author":"SO Dalton","year":"2007","unstructured":"Dalton SO, Ross L, D\u00fcring M, Carlsen K, Mortensen PB, Lynch J, Johansen C: Influence of socioeconomic factors on survival after breast cancer--a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983\u20131999. Int J Cancer 2007, 121: 1983\u20131999. 10.1002\/ijc.22979","journal-title":"Int J Cancer"},{"key":"619_CR130","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/cncr.22664","volume":"109","author":"XL Du","year":"2007","unstructured":"Du XL, Meyer TE, Franzini L: Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer 2007, 109: 2161\u20132170. 10.1002\/cncr.22664","journal-title":"Cancer"},{"key":"619_CR131","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1188\/09.ONF.79-88","volume":"36","author":"KT Ashing-Giwa","year":"2009","unstructured":"Ashing-Giwa KT, Lim JW: Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncol Nurs Forum 2009, 36: 79\u201388. 10.1188\/09.ONF.79-88","journal-title":"Oncol Nurs Forum"},{"key":"619_CR132","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijrobp.2007.05.056","volume":"70","author":"AN Demiral","year":"2008","unstructured":"Demiral AN, Sen M, Demiral Y, Kinay M: The effect of socioeconomic factors on quality of life after treatment in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 70: 23\u201327. 10.1016\/j.ijrobp.2007.05.056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"619_CR133","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10549-006-9479-2","volume":"106","author":"DJ Bowen","year":"2007","unstructured":"Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K, Baumgartner KB, Fetherolf J, Reeve BB, Smith AW, Ganz PA, McTiernan A, Barbash RB: Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 2007, 106: 85\u201395. 10.1007\/s10549-006-9479-2","journal-title":"Breast Cancer Res Treat"},{"key":"619_CR134","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7525-1-19","volume":"1","author":"A Montazeri","year":"2003","unstructured":"Montazeri A, Hole DJ, Milroy R, McEwen J, Gillis CR: Quality of life in lung cancer patients: does socioeconomic status matter? Health Qual Life Outcomes 2003, 1: 19. 10.1186\/1477-7525-1-19","journal-title":"Health Qual Life Outcomes"},{"key":"619_CR135","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/bmj.325.7372.1066","volume":"325","author":"M Petticrew","year":"2002","unstructured":"Petticrew M, Bell R, Hunter D: Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 2002, 325: 1066. 10.1136\/bmj.325.7372.1066","journal-title":"BMJ"},{"key":"619_CR136","doi-asserted-by":"publisher","first-page":"R44","DOI":"10.1186\/bcr1744","volume":"9","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI: The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res 2007, 9: R44. 10.1186\/bcr1744","journal-title":"Breast Cancer Res"},{"key":"619_CR137","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/ncponc1134","volume":"5","author":"Y Chida","year":"2008","unstructured":"Chida Y, Hamer M, Wardle j, Steptoe A: Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 2008, 5: 466\u2013475. 10.1038\/ncponc1134","journal-title":"Nat Clin Pract Oncol"},{"key":"619_CR138","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s11136-008-9357-y","volume":"17","author":"ME Mauer","year":"2008","unstructured":"Mauer ME, Bottomley A, Coens C: Statistical methodology is crucial in prognostic factor analysis of health-related quality of life. Qual Life Res 2008, 17: 1043\u20131044. 10.1007\/s11136-008-9357-y","journal-title":"Qual Life Res"},{"key":"619_CR139","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1586\/14737167.8.2.179","volume":"8","author":"ME Mauer","year":"2008","unstructured":"Mauer ME, Bottomley A, Coens C, Gotay C: Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation. Expert Rev Pharmacoecon Outcomes Res 2008, 8: 179\u2013196. 10.1586\/14737167.8.2.179","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"619_CR140","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/annonc\/mdl123","volume":"17","author":"A Bottomley","year":"2006","unstructured":"Bottomley A, Efficace F: Predicting survival in advanced cancer patients: is it possible with patient-reported health status data? Ann Oncol 2006, 17: 1037\u20131038. 10.1093\/annonc\/mdl123","journal-title":"Ann Oncol"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-7-102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7525-7-102\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-7-102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T13:05:23Z","timestamp":1711026323000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-7-102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/1477-7525-7-102","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]},"article-number":"102"}}